148 filings
Page 3 of 8
6-K
30fryfb 1t7x5isx9
22 Jun 23
Theratechnologies Draws Down on US$20 Million Second Tranche Under its Term Loan Facility With Affiliates of Marathon Asset Management
8:00am
6-K
p8n qgpvcl5iepbax2y
2 Jun 23
Theratechnologies Receives FDA Agreement to Amended Trial Protocol for its Lead PDC Candidate Sudocetaxel Zendusortide
1:02pm
6-K
vktv0213wc
10 May 23
Report on Voting Results
3:47pm
6-K
27rrhy1htv45xg
9 May 23
Theratechnologies Reports on its Annual Meeting of Shareholders
2:48pm
6-K
xxbb 0iois
13 Apr 23
Notice of Annual Meeting of Shareholders
8:01am
6-K
jul8enc1wr
12 Apr 23
Interim Consolidated Financial Statements
8:00am
6-K
g4e6bv
12 Apr 23
Theratechnologies Reports Financial Results and Business Updates for First Quarter 2023
7:45am
6-K
p3j3cg5v
7 Mar 23
Theratechnologies Receives Nasdaq Notification Letter Regarding Share Price
10:26am
6-K
b0r4h6lummw
28 Feb 23
Theratechnologies Reports Financial Results
8:01am
6-K
k6l8 kg20m
28 Feb 23
Theratechnologies Announces Amendment to its Term Loan Facility With Affiliates of Marathon Asset Management
7:00am
6-K
7sy hnd89l
17 Jan 23
Material Change Report
6:07am
6-K
4b555ldr3j
4 Jan 23
Theratechnologies Announces Fiscal Year 2023 Guidance and Operating Plan’s Key Objectives
9:22am
6-K
d4w7g2nd2qe 542sn0tj
12 Dec 22
Material Change Report
12:42pm
6-K
wemb4f7ra4j naogb1be
2 Dec 22
Theratechnologies Announces Update from Ongoing TH1902 Study
12:57pm
6-K
d05hy 23wl
13 Oct 22
Interim Consolidated Financial Statements
8:01am
6-K
0v2e4ko
13 Oct 22
Theratechnologies Reports Financial Results
7:45am
6-K
a79bcxktjvgp 96
28 Jul 22
Theratechnologies Announces Closing of Funding of $40 Million Under the Terms of its Credit Agreement
9:48am
6-K
7hdnigo
21 Jul 22
Material Change Report
4:40pm
6-K/A
ifwhst8nn
20 Jul 22
Theratechnologies Announces Binding Commitment for a
3:13pm
6-K
mz319qoat bc
14 Jul 22
Interim Consolidated Financial Statements
8:00am